Differential in vivo regulation of TH and DBH mRNA in rat atria by maprotiline and fluoxetine
Author(s) -
Nataša Spasojević,
Predrag Jovanović,
Vera Spasojević-Tišma,
Ninoslav Djelić,
Sladjana Dronjak
Publication year - 2011
Publication title -
archives of biological sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 25
eISSN - 1821-4339
pISSN - 0354-4664
DOI - 10.2298/abs1103597s
Subject(s) - fluoxetine , maprotiline , endocrinology , norepinephrine transporter , medicine , monoaminergic , tyrosine hydroxylase , reuptake , catecholamine , serotonin reuptake inhibitor , chemistry , dopamine , in vivo , pharmacology , serotonin , biology , norepinephrine , antidepressant , receptor , hippocampus , microbiology and biotechnology
It is well known that antidepressants affect central monoaminergic neurotransmission and that they also modulate hormone release in peripheral tissues. Repeated maprotiline (a noradrenaline reuptake inhibitor) and fluoxetine (a serotonin reuptake inhibitor) treatment on gene expression of the catecholamine biosynthetic enzymes were examined in rat atria and ventricles in vivo. Maprotiline decreased the gene expression of tyrosine hydroxylase (TH) and dopamineβ-hydroxylase (DBH) in the rat atrium. Fluoxetine increased gene expression of TH and DBH, but not of phenylethanolamine N-methyltransferase (PNMT). Chronic application of antidepressants did not change the expression of these enzymes in the ventricles. We conclude that repeated administration of fluoxetine enhances gene transcription of TH and DBH and subsequently stimulates noradrenaline synthesis in rat atria in vivo
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom